Bajra Pharma Private Limited
About Bajra Pharma Private Limited
Data last updated:
Bajra Pharma Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the diversified financial services segment of the financial services sector. It was incorporated on 30 October 2003.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2003PTC122861.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.97 Lakh. It was led by directors Ashok Kumar Sharma and Pramod Kumar Basotia.
Its last annual general meeting (AGM) was held on 18 November 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Shop No 18 Csc – 3 Sector 2, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2020, the company reported a revenue of ₹44.98 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net profit of ₹64,223 (net margin 1.4%) and EBITDA of ₹97,523 (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 5% over five years.
Court records list 1 case involving the company, including 1 filed by the company.
Company details
Contact details
Bajra Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No 18 Csc – 3 Sector 2, New Delhi, Delhi, India – 110085
- IndustryFinancial Services, Diversified Financial Services
To see the full contact details of Bajra Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bajra Pharma is financial and insurance service. In detail, this covers other financial activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| K | Financial and insurance Service | K8 | Other financial activities |
To see the full business activity and turnover split of Bajra Pharma Private Limited, buy the company report.
Financials of Bajra Pharma Private Limited
FY 2020 filings availableBajra Pharma Private Limited reported revenue of ₹44.98 Lakh (down 24% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 24% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹97,523 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹64,223 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bajra Pharma Private Limited, buy the company report.
Board of directors of Bajra Pharma Private Limited
Bajra Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashok Kumar Sharma Also directs: Upercon Marketing Private Limited, Growth Well Finlease Private Limited, Unmukh Builders Private Limited and 5 more | Director | 30 Oct 2003 | 23 Years 0 Months | As last reported |
| Pramod Kumar Basotia | Director | 06 Mar 2012 | 14 Years 8 Months | As last reported |
Peer comparison
Bajra Pharma Private Limited is compared with the 3 companies closest to it by revenue in the BFSI industry (Other Financial Services), with the same principal business activity (other financial activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Betul Commercial Ltd | ₹45.06 Lakh (FY 2023) | -21.0% | Kolkata, West Bengal, India | |||
| Kiran Probuild Private Limited | ₹45.03 Lakh (FY 2025) | -80.0% | Delhi, India | |||
| Bajra Pharma Private Limitedthis company | ₹44.98 Lakh (FY 2020) | ₹64,223 | 1.4% | -24.0% | New Delhi, Delhi, India | |
| Aasl (India) Properties and Infrastructure Private Limited | ₹44.92 Lakh (FY 2024) | 70.0% | New Delhi, Delhi, India |
To see the full peer comparison of Bajra Pharma Private Limited, buy the company report.
Auditor
Bajra Pharma Private Limited is audited by DEEPTI JAIN & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEEPTI JAIN & CO | FY 2019 | 018225N |
Shareholding
The shareholding of Bajra Pharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Bajra Pharma Private Limited, buy the company report.
Legal cases
Bajra Pharma Private Limited has 1 court case on record: 1 filed by Bajra Pharma. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Writ petition | Filed by the company against Income Tax Officer | Disposed |
To see the full case history of Bajra Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bajra Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bajra Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bajra Pharma Private Limited has 3 board changes on record since 2003: 2 appointments and 1 cessation. The latest: Deepak Kumar Sharma ceased to be Director on 06 Mar 2012.
Frequently asked questions
Bajra Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Bajra Pharma was a private limited company based in New Delhi, Delhi, India. The company worked in diversified financial services, within the financial services industry. It was incorporated on 30 October 2003 and is registered under CIN U24231DL2003PTC122861. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Bajra Pharma was incorporated on 30 October 2003. It is registered with the Registrar of Companies, Delhi.
Bajra Pharma had 2 directors:
- Ashok Kumar Sharma - Director
- Pramod Kumar Basotia - Director
The CIN (Corporate Identification Number) of Bajra Pharma is U24231DL2003PTC122861. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Bajra Pharma is at Shop No 18 Csc – 3 Sector 2, New Delhi, Delhi, India – 110085.
The latest financial statements of Bajra Pharma on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 18 November 2020. Year-wise statements from 2015 are in the company report.
Bajra Pharma operated in the financial services industry, in the diversified financial services segment.
The peers of Bajra Pharma by revenue are Betul Commercial Ltd, Kiran Probuild Private Limited, Aasl (India) Properties and Infrastructure Private Limited, all in the BFSI industry (Other Financial Services), with the same principal business activity (other financial activities).
Bajra Pharma has 1 court case on record: 1 filed by the company.
Deepak Kumar Sharma ceased to be Director on 06 Mar 2012. Pramod Kumar Basotia was appointed as Director on 06 Mar 2012. Ashok Kumar Sharma was appointed as Director on 30 Oct 2003.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
